Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Diabetology & Metabolic Syndrome
|
February 20, 2014
Effect of moderate alcohol consumption on fetuin-A levels in men and women: post-hoc analyses of three open-label randomized crossover trials
Michel M Joosten, Ilse C Schrieks, Henk Fj Hendriks
Clinical Physiology and Functional Imaging
|
June 16, 2011
Comparison study of treadmill versus arm ergometry
Ilse C Schrieks, Matthew J Barnes, Lynette D Hodges
Plos One
|
May 12, 2015
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial
Ilse C Schrieks, Dina Ripken, Annette Stafleu, et al.
Plos One
|
January 28, 2014
The biphasic effects of moderate alcohol consumption with a meal on ambiance-induced mood and autonomic nervous system balance: a randomized crossover trial
Ilse C Schrieks, Annette Stafleu, Victor L Kallen, et al.
Diabetes Care
|
March 26, 2015
The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies
Ilse C Schrieks, Annelijn L J Heil, Henk F J Hendriks, et al.
Appetite
|
February 1, 2015
Moderate alcohol consumption stimulates food intake and food reward of savoury foods
Ilse C Schrieks, Annette Stafleu, Sanne Griffioen-Roose, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
August 4, 2012
Effect of red wine consumption on biomarkers of oxidative stress
Ilse C Schrieks, Robin van den Berg, Aafje Sierksma, et al.
European Journal of Preventive Cardiology
|
February 11, 2017
The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial
Sigrid Cj van Steen, Ilse C Schrieks, Joost Bl Hoekstra, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2019
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial
Jeroen V Koomen, Hiddo J L Heerspink, Ilse C Schrieks, et al.
Plos One
|
November 15, 2022
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Esmée J Grobbee, Vivian D de Jong, Ilse C Schrieks, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Diabetology & Metabolic Syndrome
|
February 20, 2014
Effect of moderate alcohol consumption on fetuin-A levels in men and women: post-hoc analyses of three open-label randomized crossover trials
Michel M Joosten, Ilse C Schrieks, Henk Fj Hendriks
Clinical Physiology and Functional Imaging
|
June 16, 2011
Comparison study of treadmill versus arm ergometry
Ilse C Schrieks, Matthew J Barnes, Lynette D Hodges
Plos One
|
May 12, 2015
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial
Ilse C Schrieks, Dina Ripken, Annette Stafleu, et al.
Plos One
|
January 28, 2014
The biphasic effects of moderate alcohol consumption with a meal on ambiance-induced mood and autonomic nervous system balance: a randomized crossover trial
Ilse C Schrieks, Annette Stafleu, Victor L Kallen, et al.
Diabetes Care
|
March 26, 2015
The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies
Ilse C Schrieks, Annelijn L J Heil, Henk F J Hendriks, et al.
Appetite
|
February 1, 2015
Moderate alcohol consumption stimulates food intake and food reward of savoury foods
Ilse C Schrieks, Annette Stafleu, Sanne Griffioen-Roose, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
August 4, 2012
Effect of red wine consumption on biomarkers of oxidative stress
Ilse C Schrieks, Robin van den Berg, Aafje Sierksma, et al.
European Journal of Preventive Cardiology
|
February 11, 2017
The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial
Sigrid Cj van Steen, Ilse C Schrieks, Joost Bl Hoekstra, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2019
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial
Jeroen V Koomen, Hiddo J L Heerspink, Ilse C Schrieks, et al.
Plos One
|
November 15, 2022
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Esmée J Grobbee, Vivian D de Jong, Ilse C Schrieks, et al.
Page
of 3